Sponsor overview

LigaChem Biosciences, .

Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.

Summary

Signal counts

Assets tracked: 1

Watchlist assets: 0

Registry stop assets: 0

Evidence links

Public sources

https://clinicaltrials.gov/study/NCT07460375

Assets

Linked programs